Sign in to follow
Search Results

0 results for 'Celgene Corporation'

You can use to get even better search results
February 13, 2014 |

Ex-Employee Brings Qui Tam Action Against Celgene for Cancer Off-Label Use

A former employee of drug maker Celgene is alleging in her qui tam complaint that the company "preyed on [the] vulnerable patient population" of cancer patients by marketing two of its drugs for off-label purposes.
2 minute read
December 03, 2013 |

Latham, Dechert Close $177 Million OncoMed Deal

2 minute read
December 02, 2013 |

Christie Chief of Staff Kevin O'Dowd To Be New Jersey Attorney General

Gov. Chris Christie announces that he will nominate his chief of staff and long-time confidant Kevin O'Dowd as New Jersey's next attorney general.
3 minute read
August 01, 2008 |

Buchanan Bounced From Drug Case Due to Defective Conflict Waivers

A federal judge in Newark has ousted Buchanan, Ingersoll & Rooney from a patent-infringement case for representing two companies with adverse interests, finding client waivers inadequate to resolve the conflict.
4 minute read
August 17, 2012 |

Thomas Moriarty Gets First GC Title at Celgene Corp.

As general counsel and corporate secretary for multinational pharmaceutical company Celgene Corporation, Thomas Moriarty will be working for a company with a broad global reach.
3 minute read
December 05, 2008 |

Advance Waivers of Conflicts of Interest

Advance waivers are becoming more commonplace and critical as law firms rely upon them to protect client relationships and for future strategic planning.
7 minute read
August 07, 2008 |

Buchanan Ingersoll Bounced From Drug Case Due to Defective Conflict Waivers

A federal judge in Newark, N.J., has ousted Buchanan, Ingersoll & Rooney from a patent infringement case for representing two companies with adverse interests, finding client waivers inadequate to resolve the conflict. U.S. Magistrate Judge Madeline Cox Arleo said the waivers were "very open-ended and vague" and that Buchanan Ingersoll did not explain the risks or reasonably available alternatives to its dual representation. The waivers thus do not demonstrate informed consent, she ruled.
4 minute read
May 10, 2012 |

Schmidt v. Celgene Corp.

Neither the doctrine of substantial compliance nor the doctrine of equitable tolling permits plaintiff, who filed an initial action in Texas, to proceed in this CEPA action filed well after CEPA's one-year statute of limitations.
5 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources